9 Results for "

HIV-Tat

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "HIV-Tat" in MCE Product Catalog:

Cat. No.: HY-P1801A
Synonyms: Cys-[HIV-Tat (47-57)] TFA
Target:  

HIV Drug Derivative

Research Areas:  

Others

Cys-TAT(47-57) (Cys-[HIV-Tat (47-57)]) TFA, TAT (HY-P0281) derivative, is a Cysteine (HY-Y0337)-tagged cell-penetrating peptide (CPP) derived from the HIV TAT protein. Cys-TAT(47-57) TFA can be used for the research for the research of drug delivery .
loading...
    loading...
Cat. No.: HY-111351
CAS No.: 1627729-62-7
Purity:  99.07%
Target:  

Mixed Lineage Kinase

Research Areas:  

Neurological Disease

MLK-IN-1 is a potent, brain penetrant and specific mixed lineage kinase 3 (MLK-3) inhibitor, compound 68, extracted from patent US20140256733A1 .
loading...
    loading...
Cat. No.: HY-P10839
CAS No.: 371915-62-7
Target:  

NF-κB

Research Areas:  

Inflammation/Immunology

NBD peptide inhibits NF-κB signaling pathway through inhibition of the NEMO-IKK complex combination. NBD peptide exhibits anti-inflammatory efficacy through block of pro-inflammatory cytokines production. NBD peptide exhibits immunosuppressive activity through regulation of immune cells. NBD peptide enhances its transmembrane ability by combining with cell-penetrating peptide HIV-TAT .
loading...
    loading...
Cat. No.: HY-P1801
CAS No.: 583836-55-9
Synonyms: Cys-[HIV-Tat (47-57)]
Target:  

HIV Drug Derivative

Research Areas:  

Others

Cys-TAT(47-57) (Cys-[HIV-Tat (47-57)]), TAT (HY-P0281) derivative, is a Cysteine (HY-Y0337)-tagged cell-penetrating peptide (CPP) derived from the HIV TAT protein. Cys-TAT(47-57) can be used for the research for the research of drug delivery .
loading...
    loading...
Cat. No.: HY-175535
CAS No.: 1940118-42-2
SRI-32743 is an allosteric human dopamine transporter (hDAT) modulator (IC50=9.86 μM). SRI-32743 is promising for research of HIV-Tat-induced neurotoxicity .
loading...
    loading...
Cat. No.: HY-P5320
Target:  

Apoptosis

Research Areas:  

Others

TAT-BH4 (Bcl-xL) localized mainly at the mitochondria, prevents apoptotic cell death. TAT-BH4 (Bcl-xL) is a fusion peptide that combines the N-terminal cysteine conjugated protein transduction domain of HIV TAT protein (amino acids 49 to 57) with the Bcl-xL BH4 peptide. TAT-BH4 can be used for research of diseases caused by accelerated apoptosis .
loading...
    loading...
Cat. No.: HY-P10076
Synonyms: L-HIV-Tat(48–57)-PP-JBD20
Target:  

JNK

Research Areas:  

Metabolic Disease

TAT-JBD20 (L-HIV-TAT(48–57)-PP-JBD20) is a JNK peptide inhibitor. TAT-JBD20 can be used for research of diabetes .
loading...
    loading...
Cat. No.: HY-P5320A
Target:  

Apoptosis

Research Areas:  

Others

TAT-BH4 (Bcl-xL) TFA is localized mainly at the mitochondria, prevents apoptotic cell death. TAT-BH4 (Bcl-xL) is a fusion peptide that combines the N-terminal cysteine conjugated protein transduction domain of HIV TAT protein (amino acids 49 to 57) with the Bcl-xL BH4 peptide. TAT-BH4 TFA can be used for research of diseases caused by accelerated apoptosis .
loading...
    loading...
Cat. No.: HY-111351R
CAS No.: 1627729-62-7
MLK-IN-1 (Standard) is the analytical standard of MLK-IN-1 (HY-111351). This product is intended for research and analytical applications. MLK-IN-1 is a potent, brain penetrant and specific mixed lineage Kinase 3 (MLK-3) inhibitor, compound 68, extracted from patent US20140256733A1 .
loading...
    loading...